Cutaneous T-Cell Lymphoma/Mycosis Fungoides (DBCOND0114878)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06588868	Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT05380635	PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma	Hypericin	other	2	completed
NCT03837457	PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study	Cobomarsen	treatment	2	terminated
NCT03713320	SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides	Cobomarsen Vorinostat	treatment	2	terminated
NCT06113081	Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT04702503	Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)	MOL-4239	treatment	1	completed
NCT06436677	A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma	No drug interventions	Not Available	Not Available	recruiting
NCT06149247	HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL	Hypericin Mechlorethamine	treatment	2	completed